FOLH1 and neoplasm: The PC-3 PIP tumor model expresses PSMA at a higher level and more homogeneously throughout the xenografts than the C4-2 model (Figure 5), which may not reflect the natural abundance and heterogeneity of PSMA in human cancer [22,35,86].